Correlation Between Virpax Pharmaceuticals and Elevation Oncology
Can any of the company-specific risk be diversified away by investing in both Virpax Pharmaceuticals and Elevation Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virpax Pharmaceuticals and Elevation Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virpax Pharmaceuticals and Elevation Oncology, you can compare the effects of market volatilities on Virpax Pharmaceuticals and Elevation Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virpax Pharmaceuticals with a short position of Elevation Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virpax Pharmaceuticals and Elevation Oncology.
Diversification Opportunities for Virpax Pharmaceuticals and Elevation Oncology
0.71 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Virpax and Elevation is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Virpax Pharmaceuticals and Elevation Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elevation Oncology and Virpax Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virpax Pharmaceuticals are associated (or correlated) with Elevation Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elevation Oncology has no effect on the direction of Virpax Pharmaceuticals i.e., Virpax Pharmaceuticals and Elevation Oncology go up and down completely randomly.
Pair Corralation between Virpax Pharmaceuticals and Elevation Oncology
Given the investment horizon of 90 days Virpax Pharmaceuticals is expected to under-perform the Elevation Oncology. In addition to that, Virpax Pharmaceuticals is 1.13 times more volatile than Elevation Oncology. It trades about -0.02 of its total potential returns per unit of risk. Elevation Oncology is currently generating about -0.02 per unit of volatility. If you would invest 65.00 in Elevation Oncology on August 23, 2024 and sell it today you would lose (4.00) from holding Elevation Oncology or give up 6.15% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Virpax Pharmaceuticals vs. Elevation Oncology
Performance |
| Timeline |
| Virpax Pharmaceuticals |
| Elevation Oncology |
Virpax Pharmaceuticals and Elevation Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Virpax Pharmaceuticals and Elevation Oncology
The main advantage of trading using opposite Virpax Pharmaceuticals and Elevation Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virpax Pharmaceuticals position performs unexpectedly, Elevation Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elevation Oncology will offset losses from the drop in Elevation Oncology's long position.| Virpax Pharmaceuticals vs. Revelation Biosciences | Virpax Pharmaceuticals vs. Palisade Bio | Virpax Pharmaceuticals vs. Virax Biolabs Group | Virpax Pharmaceuticals vs. Quoin Pharmaceuticals Ltd |
| Elevation Oncology vs. Ocean Biomedical | Elevation Oncology vs. Zura Bio Limited | Elevation Oncology vs. Enveric Biosciences | Elevation Oncology vs. Hepion Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Correlations Find global opportunities by holding instruments from different markets |